Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Life Science Valley Wachstumsfonds is an early-stage venture capital fund located in Göttingen, Niedersachsen, Germany. Founded in December 2022, the fund aims to foster innovation within the regional life sciences ecosystem by providing essential funding and resources to promising startups and emerging companies. The firm is dedicated to supporting the growth of early-stage companies that leverage the region's strong research capabilities and technological advancements.
As of now, Life Science Valley Wachstumsfonds focuses on pre-seed, seed, and seed-plus stages, targeting investments primarily in Niedersachsen. The fund's strategy is to identify and support startups that address significant unmet clinical needs, ensuring they have a clear path to market readiness. This approach aligns with the fund's mission to enhance the life sciences sector in the region.
The investment strategy of Life Science Valley Wachstumsfonds encompasses various sectors within the life sciences, including biotechnology, medical technology, digital health, and agriscience. The fund specifically targets early-stage companies that are based in Niedersachsen and are leveraging the region's strong life science research and technologies. This focus allows the fund to capitalize on local innovations and advancements.
Life Science Valley Wachstumsfonds seeks to support startups that are addressing unmet clinical needs and have a clear development path to market readiness. The fund typically invests in pre-seed, seed, and seed-plus stages, providing check sizes that align with the needs of early-stage companies. This targeted approach enables the fund to play a crucial role in the growth of the life sciences sector in Germany.
Life Science Valley Wachstumsfonds has made notable investments in several innovative companies within the life sciences sector. The portfolio includes:
These companies exemplify the fund's commitment to supporting startups that address significant market needs and leverage cutting-edge technologies.
Marco Janezic: Managing Director, responsible for fund development, investor network, and fundraising. He has extensive experience in venture capital and startup ecosystems.
Dr. Sven Wagner: Managing Director, also focused on fund development, investor network, and fundraising. He brings a strong background in life sciences and investment.
Naomi Kramer: Investment Associate, involved in venture building, scientific due diligence, and value creation. She has a background in life sciences and investment analysis.
Gabriele Burgstaller: Controller, an expert in finance and controlling, ensuring the fund's financial health and compliance.
To pitch to Life Science Valley Wachstumsfonds, founders should send their proposals via email to info@lsv-ventures.de. It is important to include a comprehensive deck that outlines the business model, market opportunity, and how the startup addresses unmet clinical needs. Founders should expect a response within a reasonable timeframe, although specific timelines may vary.
Since its founding in December 2022, Life Science Valley Wachstumsfonds has actively built its portfolio, which includes companies like brainQr Therapeutics, Digity GmbH, and Cultimate Foods. The fund continues to seek new investment opportunities within the life sciences sector, focusing on innovative startups that align with its mission.
As of now, there have been no public announcements regarding exits or additional fund raises, but the firm is expected to continue expanding its portfolio in the coming months.
What are the investment criteria for Life Science Valley Wachstumsfonds?
The fund invests in early-stage companies within the life sciences sector, focusing on those that leverage Niedersachsen's strong research and technologies. It seeks startups addressing unmet clinical needs with a clear path to market readiness.
How can I apply or pitch to Life Science Valley Wachstumsfonds?
Founders can pitch their ideas by contacting the fund via email at info@lsv-ventures.de. It is advisable to provide a detailed overview of the business model, market potential, and how the startup addresses unmet clinical needs.
What makes Life Science Valley Wachstumsfonds different from other venture capital firms?
The fund's unique focus on the Niedersachsen region allows it to leverage local research and technological advancements in the life sciences sector. This regional emphasis enhances its ability to identify and support promising startups.
What is the geographic scope of the fund's investments?
Life Science Valley Wachstumsfonds primarily invests in early-stage companies located in Niedersachsen, Germany, but may consider opportunities in other parts of Europe that align with its investment thesis.
What is the fund size and typical check size?
The fund focuses on pre-seed, seed, and seed-plus stages, with check sizes tailored to the needs of early-stage companies. Specific fund size details are not disclosed, but the emphasis is on supporting startups at critical growth phases.
What kind of post-investment involvement can startups expect?
Life Science Valley Wachstumsfonds provides ongoing support to its portfolio companies, including access to resources, mentorship, and networking opportunities within the life sciences sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.